URSODEOXYCHOLIC ACID FOR THE PREVENTION OF SYMPTOMATIC GALLSTONE DISEASE AFTER BARIATRIC SURGERY: A MULTICENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED SUPERIORITY TRIAL

Sylke Haal  1     Maimoena S.S. Guman  1     Thomas C.C. Boerlage  2     Yair I.Z. Acherman  3     L. Maurits de Brauw  3     Sjoerd Bruin  3     Steve M.M. de Castro  4     Jeanin van Hooft  5     Arnold W.J.M. van de Laar  3     Daan E. Moes  6     Manon Schouten  7     Ruben Schouten  7     Ellert J. van Soest  3     Ruben N. van Veen  4     Claire E.E. de Vries  4     Paul Fockens  1     Marcel G.W. Dijkgraaf  1     Victor E.A. Gerdes  1     Rogier P. Voermans  1    
1 Amsterdam UMC, Locatie AMC/University of Amsterdam, Amsterdam, Netherlands
2 UMCU, Utrecht, Netherlands
3 Spaarne Gasthuis, Hoofddorp, Netherlands
4 OLVG, Amsterdam, Netherlands
5 Leiden University Medical Center, Leiden, Netherlands
6 Dijklander Ziekenhuis, Hoorn, Netherlands
7 Flevoziekenhuis, Almere, Netherlands

Topic
Hepatobiliary

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing